Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Inside the Lab Liquid biopsy, Oncology, Genetics and epigenetics, Clinical care, Screening and monitoring, Precision medicine, Omics

Advancing liquid biopsy research using next-generation sequencing: A multi-centre lung cancer cell-free DNA (cfDNA) study

sponsored by Thermo Fisher Scientific

Tumour-specific mutations in plasma can serve as biomarkers for tumour detection, monitoring tumour response to therapies, detecting residual disease, and enabling long-term follow-up. In this webinar, you will learn:

  • Why liquid biopsy can represent temporal and spatial heterogeneity in cancer progression
  • The importance of using next-generation sequencing (NGS) methods in liquid biopsy research studies

View on-demand

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine